Alicia Gerke is a Respiratory physician affiliated with University of Iowa. OpenAlex indexes 93 publications with 3,691 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Iowa City, IA 522421009
Telephone
319-356-1616Registry record last updated 15 Jun 2009.
Clinical trials
- Human Lung Responses to Respiratory Pathogens
Sponsor: University of Iowa
- Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
Sponsor: Alicia Gerke
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
31.9%Endothelin Receptor Antagonist17%Opsumit59%Ambrisentan41%Part D≥16 patientsLoop diuretic6.3%Furosemide44%Torsemide41%Bumetanide14%Part D<11 patients+ 3 more classes in this area
Respiratory
15.4%Corticosteroid4.9%Trelegy Ellipta42%Breo Ellipta38%Fluticasone Propionate20%Part D<11 patientsbeta2-Adrenergic Agonist4.3%Albuterol Sulfate Hfa100%Part D≥25 patients+ 2 more classes in this area
Metabolism & gastrointestinal
14.4%Corticosteroid8.2%Prednisone100%Part D≥32 patientsProton pump inhibitor2.5%Omeprazole100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- The Role of Residential Bioaerosol Exposure in Pulmonary Sarcoidosis
University of Iowa
FY2026$783,781R01HL182922 - The Role of Residential Bioaerosol Exposure in Pulmonary Sarcoidosis
University of Iowa
FY2024$751,734R56HL173123 - Biomarkers for Severity, Therapy, and Disparity in Sarcoidosis: Discovery to Delivery
University of Iowa
FY2019$10,000R13HL147505
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Perlman, MD
University of Iowa
Mohammed Milhem, MBBS
University of Iowa
Lawrence Hunsicker, MD
University of Iowa
Michael Abramoff, MD, PhD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”